This manuscript provides an overview of past wildlife contraception efforts and discusses the current state of research. Two fertility control agents, an avian reproductive inhibitor containing the active ingredient nicarbazin and an immunocontraceptive vaccine, have received regulatory approval
INTRODUCTION
Wild animals are valuable natural resources and vital components of a healthy ecosystem. Wildlife provides economic, recreational and aesthetic benefits and, to many people, the knowledge that wildlife exists is a positive benefit in itself. For most of the past century, federal and state wildlife conservation agencies in the USA and around the world have focused on increasing populations of many species of wildlife. In many cases, such as for the whitetailed deer Odocoileus virginianus (Zimmermann, 1780) and Canada geese Branta canadensis (Linnaeus, 1758) in the USA, the badger Meles meles (Linnaeus, 1758) in Great Britain, the fox Vulpes vulpes (Linnaeus, 1758) in Europe and the wallaby Macropus eugenii (Desmarest, 1817) in Australia, these conservation efforts have been extremely successful, to the point where these species are locally overabundant and cause either ecological damage or human-wildlife conflicts, including damage to agricultural commodities, disease transmission to humans, livestock or other valued wildlife, and safety issues such as wildlife aircraft strikes. Many of the problems associated with overabundant wildlife occur in suburban or urban areas where regulation of wildlife populations through conventional means such as hunting, translocation or culling has not been feasible, or is precluded because of regulations or public perceptions. The need for wildlife management is increasing as people continue to encroach upon natural habitats and human-wildlife conflicts become more frequent. At the same time, the public is becoming intolerant of perceived inhumane means of control. A growing interest in nonlethal methods for population control of nuisance or damaging wildlife species has fostered research in wildlife contraception. Because fertility control acts by reducing birth rates, rather than by increasing mortality rates, it is perceived by the public as being more humane and morally acceptable than conventional population control methods.
This manuscript provides an overview of issues relating to the use of contraceptive agents, particularly in North America, as a means of resolving human-wildlife conflicts. In the manuscript we discuss compounds currently and previously used to control fertility in wildlife; the regulatory pathways for gaining approval of contraceptive agents and their economic feasibility; health and safety concerns for use of contraceptives; and public perceptions on use of contraceptive agents. Many contentious issues have been raised regarding the use of infertility agents for managing wildlife populations (Bomford 1990 ). The following sections will address each of these issues. This paper focuses specifically on the USA, but includes references to Europe, New Zealand and Australia, both because of collaborative research on development of wildlife contraceptives and because of new initiatives in these countries to develop anti-fertility agents for the field control of vertebrate pests (Lapidge et al. 2007) .
REVIEW OF CURRENT TECHNOLOGY FOR WILDLIFE CONTRACEPTION

Steroids/hormones
Chemical contraception through the use of synthetic steroids, estrogens and progestins was investigated widely during the 1960s and 1970s in many species (Fagerstone et al. 2002) . More recently, androgens have also been tested for use in male rodents and wolves (Canis lupus) (Asa 1997) . These steroid hormones act by interfering with ovulation or implantation of the egg in female animals or by impairing spermatogenesis in males. Unfortunately, none of the steroid compounds has gone beyond the testing stage in wildlife.
A potential use of steroids for contraception in wildlife involves the delivery of norgestomet (a progesterone approved by the Food and Drug Administration [FDA] for use in cattle for estrus synchronization) to black-tailed deer (Odocoileus hemionus) using a biobullet (Jacobsen et al. 1995; DeNicola et al. 1997a) . In Jacobsen et al. (1995) , the ten treated failed to exhibit estrous behavior during the fall rut and two treated bucks exhibited no sexual behavior for one year.
Lutalyse, produced by Upjohn (prostaglandin PGF2?), is used in feedlot cattle during the first 100 days of gestation to interfere with pregnancy. DeNicola et al. (1997b) and Waddell et al. (2001) reduced fertility in white-tailed deer (Odocoileus virginianus) by injecting Lutalyse. Levonorgestrel is the active component of the Norplant implant approved for human use as a contraceptive implant by the FDA (McCauley & Geller 1992) ; it has been used in zoos but is not effective in deer (Plotka & Seal 1989; White et al. 1994) . Medroxyprogesterone acetate (Provera) has been used in zoos. Megestrol acetate is marketed in Europe as Ovarid and in the USA as Megace, and Ovaban and is sometimes used as a contraceptive in domestic dogs (Canis familiaris Linnaeus, 1758) and cats (Felis catus Linnaeus, 1758), but it showed only weak effects on feral cats in McDonald (1980) and no effect on white-tailed deer in Matschke (1977) . Melengestrol acetate (MGA) is approved by the FDA for use in cattle as a daily administration (Zimbelman & Smith 1966) for suppression or synchronization of estrus, increased weight gain and improved feed efficiency (Bennett 1993) . It has been shown to inhibit reproduction in white-tailed deer when ingested daily (Roughton 1979) or implanted (Bell & Peterle 1975; Plotka & Seal 1989) . MGA implants have been used by zoos for approximately 20 years, but recent findings of uterine pathology in felids have raised concerns about its use (Kazensky et al. 1998) .
Some steroid hormones target males rather than females (Asa 1997) . Bisdiamine is a compound that selectively interferes with spermatogenesis but not testosterone production. When administered in ground meat daily to gray wolves it suppressed spermatogenesis without affecting mating behavior (Asa et al. 1996) . Indenopyridine also blocks sperm production; it has been tested in rodents and dogs (Chang et al. 2002) . Alpha-chlorohydrin (Epibloc), a male chemosterilant, was approved by the Environmental Protection Agency (EPA) for use as a rat control agent in 1982 (Bowerman & Brooks 1971; Ericsson 1982; Andrews & Belknap 1983) but is no longer marketed. At low doses it caused temporary sterilization, with time to recovery of fertility dependent on dose. A single high dose caused permanent sterility but showed toxic effects. In addition, rats (Rattus spp.) have a promiscuous mating system, so targeting only male rats offered little promise as a population control technique.
Despite considerable effort, steroid hormones have not been used successfully to inhibit reproduction in overabundant animals. Although steroids can be fed orally or implanted, they are effective for only a short period and need repetitive applications, making them costly and impractical in most field situations. Some steroids, such as diethylstilbestrol (DES), persist in tissue and in the food chain, making them unsatisfactory from an environmental point of view. They can also have deleterious health effects on treated animals. For example, DES was found to be a teratogen when given to pregnant women.
Chemicals that cause premature ovarian failure (senescence)
In most species of mammals, the female is born with a finite number of primordial follicles. The number of follicles that are ovulated is small compared with the total number of primordial follicles present at birth; most follicles do not develop fully, but undergo atresia (cell death) at various development stages. Follicular atresia occurs continuously in the ovary after birth until the supply of follicles is depleted and ovarian failure (menopause in women) or sterilization occurs. Scientists are currently looking into techniques that will induce early ovarian failure as a tool for reproductive control of pest animals.
One chemical that has been shown to destroy oocytes contained in primordial and primary follicles is 4-vinylcyclohexene diepoxide (VCD). The compound 4-vinylcyclohexene (VCH) is used in the synthesis of rubber products, insecticides, flame retardants, antioxidants and plasticizers. In vivo, VCH is metabolized to VCD by cytochrome P450-catalyzed epoxidation (Hu et al. 2006) . Medical researchers investigating the mechanisms of premature ovarian failure and menopause use VCD to induce these conditions in rodent models. Repeated exposure to VCD selectively destroys primordial and primary follicles by increasing the rate of follicular atresia, ultimately depleting the ovary of most of the existing follicles and causing ovarian senescence (Mayer et al. 2004; Hue et al. 2006) . This leads to a hormonal profile comparable to a female in menopause, characterized by high luteinizing hormone (LH) and follicle stimulating hormone (FSH) concentrations and decreased estradiol concentrations. Mayer et al. (2004) report that repeated exposure of VCD depletes small pre-antral (primordial and primary) ovarian follicles, resulting in follicle depletion and ovarian failure. Ten days of VCD treatment appears to be the minimum number of days required to initiate ovotoxic effects; approximately half the follicle supply is depleted after 15 days of treatment, and almost all follicles are depleted after 30 days of treatment (Springer et al. 1996; Mayer et al. 2004; Hu et al. 2006) . This compound could, therefore, be used as a permanent sterilant for selected wildlife species when given in repeated doses. Mayer (2006) has begun looking at VCD as an injectable contraceptive for use in dogs (C. familiarus) and cats (Felis domesticus).
Avian contraceptives
Interfering with egg laying or the hatchability of the egg can be used to reduce reproductive capacity in birds. Egg addling, including shaking or oiling the eggs in the nest, effectively reduces egg hatchability (Pochop et al. 1998) . Egg oiling with corn oil is allowed by the EPA under the Federal Insecticide, Fungicide and Rodenticide Act (Revised October 1988) 25b exemption for natural products, and is being used to reduce reproduction in Canada geese (B. canadensis) and gulls (Larus spp.). However, this method is labor intensive and probably useful only in small areas.
Ornitrol (DiazaCon) is a cholesterol mimic that has a chemical structure similar to cholesterol (Miller & Fagerstone 2000) . It inhibits formation of pregnenolone, the parent compound of steroid hormones, preventing formation of testosterone and progesterone. DiazaCon persists in the body, so its reproductive inhibition effects can last up to several months. It was registered in the late 1960s with the EPA as the oral pigeon (Columba livia Gmelin, 1789) reproductive inhibitor Ornitrol, but the registration was cancelled in 1993. Although the drug was effective in reducing egg laying and egg hatchability (Woulfe 1968) , the pigeon is a year-round breeder and long-term use of the compound became expensive. In addition, long-term ingestion of this product at high levels might have undesirable health effects on the birds (Lofts et al. 1968) because cholesterol is necessary for a range of key processes within the body as well as the production of reproductive hormones. In recent tests, the compound was found to be effective in reducing egg laying, egg fertility and egg hatchability for 2-4 months in coturnix quail Coturnix coturnix (Linnaeus, 1758) after feeding it for 10-14 days (Yoder 2000; Yoder et al. 2004) . It was effective on both sexes, with testosterone declining in treated males and progesterone declining in treated females (Yoder et al. 2004) . DiazaCon might prove useful in controlling the reproduction of seasonally breeding bird species when fed just prior to breeding in the spring. It is being tested in the monk parakeet Myiopsitta monachus (Boddaert, 1783) in Florida, where the birds nest on power stations and power poles, causing power outages (Avery et al. 2006) . DiazaCon is not species-specific, and could potentially be effective in mammalian as well as avian species.
Conjugated linoleic acid (CLA) has been tested as an avian infertility agent for use in cold climates. It is used as a feed additive to increase weight gain and feed efficiency in broiler chickens (Chin et al. 1994) . When fed to laying chickens, CLA reduces hatchability by causing solidification of the yolk at refrigerator temperatures (Cooney 1995) . In theory, when the clutch is being laid in the spring, the bird does not incubate the nest until the clutch is complete. As the temperature drops during the night, the yolk of unincubated eggs from CLA-fed birds solidifies, interfering with hatchability. CLA is specific to avian species and its effect is reversible but it needs to be fed for 10 or more days. In a study by Aydin & Cook (2006) , CLA increased embryonic mortality in pigeon eggs to 100% after 10 weeks of feeding. However, it was ineffective in a limited field trial with Canada geese (S. Craven, University of Wisconsin, personal communication).
Nicarbazin (NCZ) is a compound approved by the FDA for control of coccidiosis in broiler chickens; if accidentally fed to breeder or layer hens, NCZ causes reduction in hatchability and egg laying due to increased permeability of the membrane between the egg white and egg yolk, which destroys the conditions necessary for development of the embryo (Jones et al. 1990 ). The ideal dose rate allows the female bird to lay eggs and sit on them, but prevents hatching. Advantages of nicarbazin are that it is specific to egg layers, it is cleared from the body within approximately 48 h and the infertility effect is reversible. A disadvantage of the compound is that it has to be fed continuously prior to and during egg laying. Nicarbazin was tested by the National Wildlife Research Center (NWRC) and subsequently registered by Innolytics LLC as a reproductive inhibitor for use in Canada geese in 2005 and for use in pigeons in 2007. Field studies show that use of Ovocontrol G immediately prior to and during the breeding season can reduce numbers and hatchability of eggs laid by Canada geese, thereby reducing recruitment of goslings into problem resident populations (Bynum et al. 2005 (Bynum et al. , 2007 
Immunocontraception vaccines
Much recent research has gone into the development of immunocontraceptive vaccines, which use the animal's immune system to produce antibodies against gamete proteins, reproductive hormones and other proteins essential for reproduction. The antibodies interfere with the biological activity of the reproductive agents (Talwar & Gaur 1987) ; the vaccines can be effective for 1-4 years or longer (Turner & Kirkpatrick 1991; Miller et al. 2000b ).
Zona pellucida vaccines
The zona pellucida (ZP) is a glycoprotein layer located on the outer surface of the egg. Antibodies to ZP result in infertility either by blocking sperm from penetrating the ZP layer or by interfering with egg maturation within the follicle (Dunbar & Schwoebel 1988) . The porcine ZP (PZP) vaccine includes both the PZP protein from the pig ovary and an adjuvant (an additive to increase the immune response). PZP has been successfully tested in numerous species, including dogs (Mahi- Brown et al. 1985) , baboons (Dunbar 1989) , coyotes (Canis latrans) (Miller 1995; DeLiberto et al. 1998; Miller et al. 2006) , burros (Equus asinus) (Turner et al. 1996) , wild horses (Equus caballus) (Kirkpatrick et al. 1990; Garrott et al. 1992; Turner et al. 2000 Turner et al. , 2002 Turner et al. , 2007 Killian et al. 2004 Killian et al. , 2006b ) and whitetailed deer (Turner et al. 1992 (Turner et al. , 1997 Miller et al. 2000a Miller et al. ,b, 2001 Fraker et al. 2002; Miller & Killian 2002) . PZP is not effective in cats (Jewgenow et al. 2000) or rodents (Drell et al. 1984) . Injecting with an initial and a booster dose of PZP vaccine has caused infertility in deer and horses for several years (Miller et al. 2000b) . A vaccine (SpayVac) developed by ImmunoVaccine Technologies and using an adjuvant developed at the National Wildlife Research Center (Adjuvac) has been effective in white-tailed deer and horses for up to four years after a single shot (Fraker et al. 2002; Killian et al. 2004 Killian et al. , 2006b ). The single-shot is a major breakthrough because animals only need to be handled once. PZP vaccines are not species-specific and are effective in reducing fertility in most mammals tested. A disadvantage of PZP in deer is that it is associated with multiple estrous cycles in does, which could result in late season births if antibody titers drop below a critical threshold late in the breeding season.
Immunocontraception with gonadotropin-releasing hormone vaccines G o n a d o t r o p i n -r e l e a s i n g h o r m o n e ( G n R H ) immunocontraceptive vaccines take advantage of the role played by GnRH in regulating mammalian reproduction. GnRH controls steroidogenesis and gametogenesis by stimulating the release of gonadotropins from the pituitary, triggering the cascade of reproductive hormones that lead to ovulation. An immunocontraceptive vaccine developed by the United States Department of Agriculture's (USDA) NWRC shows great potential as a contraceptive agent for deer and other mammals. GonaCon Immunocontraceptive Vaccine (NWRC, Fort Collins, Colorado, USA) can be administered as a single injection that suppresses reproduction in treated animals of both sexes (Miller et al. 2004b) . GonaCon Vaccine causes immunization against GnRH by stimulating the production of antibodies that neutralize GnRH in the vasculature between the hypothalamus and the anterior pituitary gland (Adams & Adams 1992; Herbert & Trigg 2005) . As a result, secretion of LH and FSH by the anterior pituitary is suppressed. In females, follicular development, ovulation and estrus are inhibited. In males, testosterone levels are reduced; testicular size and aggressive behavior decrease significantly, and no interest is shown in estrous females (Miller et al. 2004b) . As long as antibody titers to native GnRH are sufficiently elevated, reproductive behavior will be suppressed and the contraceptive effect will last in both sexes (Miller et al. 2004b) . GonaCon has induced contraception in many mammalian species, including California ground squirrels (Spermophilus beecheyi) (Nash et al. 2004) , captive Norway rats (Rattus norvegicus) (Miller et al. 1997) , domestic cats (F. catus) (Levy et al. 2004) , domestic and feral swine (Sus scrofa) (Killian et al. , 2006c Miller et al. 2003) , wild horses (Equus caballus) (Killian et al. 2004 (Killian et al. , 2006a , bison (Bison bison) (Miller et al. 2004a ) and white-tailed deer .
Gonadotropin-releasing hormone is a small hormone that is a weak antigen due to its low molecular weight and its being a "self" hormone (Herbert & Trigg 2005) . GnRH is made immunogenic by conjugating it to a large, nonself, hemocyanin protein harvested from marine mollusks (Miller et al. , 2004b ). An adjuvant is used in conjunction with the vaccine to achieve an immune response sufficient to provide contraception. The adjuvant used in GonaCon vaccine was developed at NWRC and consists of a modified USDA-approved vaccine for Johne's disease called Mycopar (Fort Dodge Animal Health, Fort Dodge, Iowa, USA). Mycopar is approved for use in food animals and, therefore, does not raise concerns regarding the consumption of GonaCon-treated deer by humans or by other non-target species (Miller et al. 2004b) .
The USDA submitted an application to the US EPA in January of 2008 for registration of GonaCon as a contraceptive agent for adult female white-tailed deer. GonaCon was approved for registration in September 2009 as a "Restricted Use" product, for use by USDA Wildlife Services or state wildlife management agency personnel or persons working under their authority. GonaCon users will also need to follow state authorization processes.
Sperm antibody vaccines
Sperm vaccines could potentially disrupt fertility in females as well as in males. Sperm head glycoproteins that bind to ZP have been identified. If these glycoproteins are used as vaccines, antibodies are produced in the female and are available to bind to sperm present in the oviduct, preventing conception by blocking the sperm from binding to the ZP surrounding the egg. Sperm protein immunocontraception is being investigated for contraception in the red fox (Vulpes vulpes), rabbit (Oryctolagus cunniculs) and tammar wallaby (Macropus eugenii) in Australia (Tyndale-Biscoe 1991; Morell 1993; Bradley 1997; Asquith et al. 2006 ).
Although not yet tested in wildlife species, contraceptive vaccines targeting sperm DNA being evaluated in laboratory rodents show some promise for future development of a sperm directed vaccine (Jagadish et al. 2006; Naz 2006 ).
Gonadotropin-releasing hormone agonist
Superactive analogs of the GnRH hormone (agonists), such as leuprolide, have been synthesized that are many times more active than naturally occurring GnRH and act to suppress the release of reproductive hormones. Longterm treatment with a GnRH agonist has been shown to prevent ovulation by decreasing GnRH receptors on gonadotropes, reducing receptor sensitivity to GnRH, decreasing pituitary LH content and by suppressing pulsatile secretion of LH and FSH (Nett et al. 1981; D'Occhio et al. 1996) . These conditions persist as long as the agonist is present, but once treatments are terminated, normal ovarian function is restored (Bergfeld et al. 1996) . Continuous treatment with a GnRH agonist inhibits ovulation in females of several species, including dogs, cattle, sheep, horses, monkeys, deer and elk (Cervus elaphus) (see Fagerstone et al. 2002) . Agonists of GnRH have been used in domestic ungulates for controlling ovarian activity, gonadal steroidogeneis and reproduction (D'Occhio et al. 2002) . However, their use in wild ungulates has been limited (Becker & Kautz 1995; Brown & Jochle 2001) , as a result, in part, to the need for continuous delivery of a therapeutic dose for the duration of the desired period of infertility. Recently, the impracticality of this approach for wildlife applications has been largely overcome by the development of long-acting biodegradable implants that can deliver a sustained release of GnRH agonist over a predetermined period of time (Ravivarapu et al. 2000; Trigg & Doyle 2001) . Controlled release, GnRH agonist formulation (ATRIGEL, Atrix Laboratories, Fort Collins, Colorado, USA) has been shown to effectively suppress reproductive function in captive and free-ranging elk, and captive mule deer (O. hemionus) for one breeding season, without significant physiological or behavioral side effects (Baker et al. 2002 (Baker et al. , 2003 (Baker et al. , 2004 . Results of recent experiments with captive elk indicate that this leuprolide formulation is equally effective in suppressing reproduction when administered either subcutaneously or with a syringe dart, thus enhancing the efficacy of management applications (Baker et al. 2005) .
Gonadotropin releasing hormone: toxin conjugate
For wild ungulates, a single-dose long-acting contraceptive offers a promising technology for population management (Hobbs et al. 2000) . A new contraceptive approach being studied involves linking synthetic analogs of GnRH to cytotoxins. By coupling a superactive analog of GnRH to a cytotoxin, it is possible to specifically target that toxin to LH-secreting and FSH-secreting cells in the anterior pituitary gland, potentially inducing permanent sterility in both sexes. Preliminary results in female mule deer indicate that a GnRH-toxin conjugate will suppress LH secretion for up to 6 months (Baker et al. 1999) .
There are a number of complex technical, biological, economic and legal issues that need to be addressed before any of the reproductive inhibitors discussed above can be used widely in field situations. One of the most important of those considerations is whether the reproductive inhibitors can be approved for use by regulatory agencies.
REGULATION OF WILDLIFE CONTRACEPTION DRUGS, WITH EMPHASIS ON THE USA
Environmental protection agencies throughout the world are encouraging the replacement of persistent or unpopular vertebrate pesticides with more humane alternative toxicants or nonlethal means of control (Eason et al. 2010) . In particular, the USA, New Zealand and Australia are undertaking collaborative research and new initiatives to develop more humane and species-targeted toxins and anti-fertility agents for the field control of vertebrate pests (Lapidge et al. 2007 ). The agencies responsible for the regulation of reproductive inhibitors for wildlife include the Australian Pesticide and Veterinary Medicine Authority, the Environmental Risk Management Authority in New Zealand and the EPA in the USA. Calls have been made for greater collaboration and harmonization in the registration of pesticides and, in particular, for vertebrate pesticides in these countries (Lapidge et al. 2007) . However, because the USA currently has the only registered reproductive inhibitors for wildlife, this review will focus on the regulatory process in the USA. Between 1996 and 2006, the regulatory agency responsible for wildlife contraceptives in the USA was the FDA, Center for Veterinary Medicine (CVM). Working under this premise, the NWRC progressed toward fulfilling the FDA's regulatory requirements by obtaining Investigational New Animal Drug (INAD) numbers for several contraceptives; these INADs allowed research to be conducted on field efficacy and target animal safety. During this time, it became clear that wildlife contraceptives were incompatible with the FDA's regulatory process. In response, the FDA and the EPA negotiated an agreement on contraceptive uses. Beginning in 2006, the EPA assumed regulatory authority over contraceptives used for wildlife and feral animals. The CVM will retain authority over all uses in captive animals, including livestock, companion animals and zoo animals.
The EPA is responsible for regulating pesticides under the Federal Insecticide, Fungicide and Rodenticide Act. Registration of a contraceptive "pesticide" by the EPA requires submission of a series of studies on product chemistry, toxicity, non-target hazards, environmental fate and efficacy. The EPA registration process can take several years. The EPA has fewer registration requirements for an injectable immunocontraceptive vaccine than for an oral product because an injectable product poses little risk of negative impact to air, water and soil, or to nontarget animals. There are currently two fertility control agents for wildlife that have received approval by the EPA. OvoControl G, an orally-delivered product, was recently registered by Innolytics, LLC (working cooperatively with the NWRC), for managing Canada geese and pigeons and is commercially available in the USA. USDA/Animal and Plant Health Inspection Service received a registration for the single-shot GonaCon Immunocontraceptive Vaccine in September, 2009 for managing white-tailed deer in areas where traditional management techniques, such as sport hunting, cannot be employed.
The two contraceptive "pesticides" currently registered are considered restricted use products and may be used only by certified pesticide applicators. The certified applicator legend has been required for several reasons: (i) training may be necessary to ensure the humane treatment of the animals (i.e. knowledge of darting, trapping and other capture methods); (ii) there may be a potential hazard to the person administering some products if they are not handled properly; and (iii) the restriction minimizes potential for inappropriate use or non-target hazards. Because wildlife are owned by the public in the USA and managed by federal and/or state wildlife agencies, these agencies need to be consulted regarding use.
BIOLOGICAL AND ECONOMIC
FEASIBILITY OF CONTRACEPTIVES
In addition to regulatory requirements, an important consideration for development of reproductive inhibitors is the practicality of their use for free-ranging wildlife. Whether fertility control is biologically feasible or economically advantageous when compared to lethal control for a particular species and population depends on a number of parameters (Curtis et al. 1997; Nielsen et al. 1997) , including whether the population is "open" or "closed," population numbers, sex ratios, age structure and estimated rate of increase and mortality of the concerned species. Dolbeer (1998) uses population models to compare the relative efficiency (i.e. percentage decline in population size relative to number of animals sterilized or removed) of reproductive control and lethal control in managing wildlife populations. The predicted relative efficiencies of lethal and reproductive control for various wildlife species (Table 1) can be generalized based on adult survival rate and age at which animals reproduce. Whether lethal control is more efficient than contraception depends on the age at first reproduction in combination with the adult survival rate. For animals that first breed at one or two years of age, lethal control is only more efficient than contraception for reducing populations when adult survival rates exceed 0.56 and 0.23, respectively. However, for animals that first breed at three years of age, lethal control will always be more efficient than contraception for reducing populations, regardless of the adult survival rate (Dolbeer 1998) . In general, this means that reproductive control will be most effective in managing species Review of reproductive inhibitors Table 1 Estimated relative efficiency of reproductive and lethal control based on numbers remaining after three years from an initially stable population of 1000 individuals in which reproductive or survival rate is reduced annually by 50% (using population models presented in Dolbeer 1998) † Efficiency ratios presented are specific to population status after three years and will increase during additional years of treatment. such as rodents or some bird species with high reproductive rates and low survival rates. Knipling and McGuire's (1972) theoretical model demonstrates that if 70% of rats can be sterilized for three generations (one year), the population will be almost eliminated, whereas a similar effort using lethal control allows the population to rebound to its original size. Reproductive control will typically be less efficient than lethal control in managing populations for larger species such as deer, coyotes and Canada geese that do not typically reproduce until 2-4 years of age and have smaller litter or clutch sizes than most rodents and small birds. Therefore, for long-lived wildlife species like deer, it may be prudent to reduce the population herd to a desired number by some other management technique before applying fertility control to stabilize herd growth (Nielsen et al. 1997) . Hobbs et al. (2000) produce a series of models examining fertility control of ungulates and conclude that >50% of fertile females need to be maintained infertile to achieve reductions in ungulate numbers. When adult survival is high (>95%), Hobbs et al. assume that 60% of breeding females need to be infertile to achieve a population reduction. Garrott (1995) and McCullough (1996) also estimate that 60-80% of adult females would require effective annual contraceptive treatment to stabilize populations with a yearly (rather than a longer-lasting) treatment. Seagle and Close (1996) suggest that sterilization of <50% of does would maintain population size over a 30-year period, whereas it would take 5-10 years to see a significant population decline with sterilization of >50% of does in a closed population. Merrill et al. (2006) determine that in a closed population, permanent fertility control could begin to reduce a population after 2-3 years, and a population reduction of approximately 60% could be achieved within 10 years if approximately 30-45% of the animals were captured annually. Hobbs et al. (2000) note that fertility control using long-lived agents could be more efficient than culling in regulating ungulate numbers, and that when contraception persists for the lifetime of the animal, models predict that, in most cases, the effort required to regulate a population at a specified density using fertility control would be less than the effort required for culling.
Economic practicality
In addition to being biologically feasible, infertility agents will need to be economically practical to use. Economic practicality involves the cost of development and authorization of the contraceptive, as well as costs of treatment, including labor, equipment and contraceptive. Field use of contraceptives can be costly. Development of single-shot GnRH and PZP immunocontraception vaccines has made their use more economically and logistically feasible than when multiple shots of vaccines were required; however, vaccines are injectable only by hand or using a biobullet or dart gun. Capture and injection by hand is preferred because animals can be individually marked when they are injected. Costs to capture and inject deer have been estimated to be greater than $250 for each deer marked (Curtis et al. 1997) . Hobbs et al. (2000) state that the expense of fertility control will not compete favorably with the revenue that could be provided by licensed hunters. They suggest that the greatest efficiency can be obtained by combining initial culling with contraceptive treatment using multi-year fertility control agents. Oral delivery would be a practical, cost-effective means to deliver contraceptive vaccines to some populations of freeroaming animals (Miller 1997) . However, oral delivery of vaccines is a difficult technology and is not expected to be developed soon.
Chemical contraceptives such as steroids, DiazaCon and nicarbazin (OvoControl G), can be delivered orally in baits but it can be difficult to get adequate bait consumption. For example, OvoControl G (used to reduce egg hatchability) must be fed to Canada geese daily for the entire egg laying period. DiazaCon also must be fed to animals several times over a 10-14 day period. These compounds must also be used over multiple years to reduce populations.
HEALTH AND SAFETY ISSUES
When the reproductive inhibitors discussed previously are used for long periods of time or are placed out into the environment, their use raises questions regarding the health and safety of: (i) target animals; (ii) non-target animals; and (iii) humans. Fagerstone et al. (2002) summarize the potential health effects of contraceptive agents. Health data on target animals have been gathered for the immunocontraceptive products PZP and GnRH. In longterm studies involving PZP and GnRH on white-tailed deer (Miller et al. 2000b,c; , animals were observed for effects on reproduction, behavior and animal health. GnRH vaccine treatments of white-tailed deer led to reduced progesterone concentrations, altered estrus behavior, contraception, failure to maintain pregnancy following conception, and reduced fawning rates . Infertility lasted up to two years without a booster injection. GnRH-immunized bucks demonstrated no sexual activity when paired with control does. Depending on the immunization schedule, antlers either dropped early or remained in velvet. Necropsies of recently vaccinated deer showed that ovaries looked normal.
A comprehensive study of toxicity and safety of use of GonCon was conducted (Killian et al. 2006c) as part of the package required by the EPA to register GonCon for use in white-tailed deer. In the 20-week study, some does were given a single injection of GonCon and some were given three injections of GonaCon at two-week intervals per dose. Blood was assayed for LH, testosterone, progesterone and anti-GnRH titers. In addition, hematology and blood chemistry were checked, and the general health of each doe was observed. At week 20, deer were killed and evaluated at necropsy by veterinary pathologists, and samples of tissues were taken for histology. There were no significant contraindications or toxic effects associated with GonaCon.
Data on health and behavioral effects related to PZP (Fagerstone et al. 2002) are available from both limited field applications (Turner et al. 1997; Warren et al. 1997; McShea et al. 1997 ) and from long-term studies (Miller et al. 2000c (Miller et al. , 2001 . A nine-year study of PZP-injected deer at Pennsylvania State University showed that vaccinated deer returned to fertility within 4-7 years after vaccinations ceased (Miller et al. 2000c) . A long-term blood chemistry survey study on PZP-immunized deer found no statistically significant health changes in vaccinated deer (Miller et al. 2001) . Over a four-year period, the health of control and treated deer were compared using measurements of body weight, serum cholesterol and blood serum chemistry profiles. No significant differences were found, suggesting that the health of the PZP-treated deer was not affected by long-term immunocontraceptive treatment (Miller et al. 2001) . However, the PZP vaccine has been shown to increase the number of times a doe comes into estrus (estrus was occasionally extended into February for white-tailed deer), thereby prolonging the breeding season and potentially resulting in late summer or autumn births . In Northern climates, fawns are typically born in spring and early summer, grow rapidly during the summer and accumulate fat reserves to draw upon during the winter when sources of adequate nutrition are minimal. Smaller late fawns lack sufficient time to prepare adequately for winter and, consequently, have a poorer body condition, reduced ability to deal with snow and colder temperatures and reduced ability to evade predators.
Nicarbazin has been used by the poultry industry in numerous countries for 45 years. It has no effects in mammal species and is safe for both target and non-target bird species, even when administered at much higher doses than needed to cause the contraceptive effect (Wildlife Services 2004; Bynum et al. 2005) . DiazaCon, as a cholesterol inhibitor, could cause health effects in either target or non-target species if fed for extended periods (Sachs & Wolfmann 1965; Yoder et al. 2004) . Trials with target species to establish appropriate dosages need to be conducted to minimize the risk of birds receiving a toxic dose.
In addition to being safe for target animals, contraceptives should not have adverse effects on non-target animals. Because technology is not currently available to make infertility agents species-specific, delivery systems should be developed to limit effects on non-target species. Delivery mechanisms such as injection, darting or implanting require direct contact with animals and will not affect non-target species. Use of oral bait delivery systems offers a way to treat larger, free-roaming populations at lower cost, but there is increased risk of unintentional treatment of non-target species. Therefore, the delivery system for contraceptive baits should be designed to exclude most non-targets. For example, an elevated bait station could be designed to allow a white-tailed deer doe to feed but exclude some non-target species.
Contraceptives used on huntable species of wildlife pose an additional safety consideration: safety to humans who may consume them. This risk is addressed by regulatory requirements of approval for drugs or pesticides. For compounds that accumulate in body tissue and could have secondary effects, such as some of the steroid contraceptives, FDA or EPA approval would not be granted for use in food animals such as deer and Canada geese without adequate data on chemical withdrawal times. Immunocontraception vaccines provide few risks for consumptive use of dosed wildlife; the antibodies that prevent reproduction are only one of millions of other antibodies present in animals, all of which are harmless to the organism that digests them, like any other proteinaceous food consisting of amino acids. Two infertility agents being researched for birds (nicarbazin and CLA) are already authorized by the FDA for use in broiler chickens and have low risk to humans. The third compound potentially proposed for birds, DiazaCon, was initially designed to be given to humans to lower serum cholesterol levels and, therefore, should present minimal hazard for human consumption at levels that would be potentially present in animal tissues.
PUBLIC ATTITUDES TOWARDS WILDLIFE FERTILITY CONTROL AGENTS
In addition to the biological, economic and legal issues that have to be considered before wildlife fertility agents can be used in field situations, these fertility agents need to be socially acceptable for that particular use. Traditionally, hunting, trapping or toxicants have been the primary management tools for controlling wildlife populations. In the USA, hunting has been the most important tool for managing most overabundant game populations. Many wildlife agencies and biologists have been reluctant to acknowledge the potential applicability of fertility control for managing wildlife populations (Warren 1995) , in part because contraceptives have been publicized as replacements for sport hunting. A survey of 134 state, regional and national agencies and organizations in the USA (Sanborn et al. 1994) found that only 9% of state wildlife agencies had an established policy on wildlife contraception, compared to 39% of 54 environmental and animal activist groups.
In large, free-ranging game populations, traditional methods of population reduction will still need to be applied because the cost and difficulty of delivery of contraceptive techniques would preclude their use. However, during the past 20 years, as farmlands and open habitats have been converted to suburban land uses, changes in wildlife distributions and density have increased the frequency of human-wildlife interactions in urban-suburban areas and parks where public hunting or trapping are not permitted by law. Local residents often experience conflicts with wildlife; many of these residents are opposed to lethal control of wildlife and support the development and use of nonlethal techniques such as contraception. Wildlife management agencies must be responsive to these suburban/urban stakeholders as well as to traditional ones. Achieving effective, humane and environmentally sensitive management of wildlife is of increasing concern to conservation biologists, wildlife managers, policy-makers and the general public. Therefore, researchers are seeking alternative means to manage wildlife, including use of contraceptives, and wildlife management agencies might be forced by the public to consider the costs and benefits of using contraception for managing wildlife populations.
Toxicants and trapping have always been relied upon heavily to control populations of non-native wildlife, such as the brush-tail possum (Trichosurus vulpecula) in New Zealand, the red fox in Australia and Germany, and the gray squirrel (Sciurus carolinensis) in Great Britain and Italy.
Surveys have shown that the public, particularly urban-suburban dwellers, are receptive to wildlife control in general and to the use of reproductive inhibitors in particular (Barr et al. 2002; Konig 2008) . Although lethal control methods are currently used most frequently for controlling non-native wildlife, the public is increasingly more amenable to nonlethal control measures, such as livetrapping and contraception (Barr et al. 2002) , and there is increasing public antipathy towards lethal methods of control. An example is the grey squirrel, which was introduced to Britain from North America in the late 1800s (Middleton 1930) . Gray squirrels compete with native red squirrels (Sciurus vulgaris) and have replaced them throughout much of Britain (Barr et al. 2002) . Despite their negative impact on red squirrel populations, gray squirrels are generally well liked by the public, who enjoy watching them. Toxicants are not publicly acceptable and translocation is not an option because, as an introduced species, gray squirrels may not be released after trapping. Contraception offers a potential nonlethal option for reducing the rate of spread of the gray squirrel.
Although currently available contraceptive techniques can sometimes be uneconomical for practical implementation, even in small localized populations of game species such as deer, they can be combined effectively with other management techniques in an integrated pest management approach. In these instances, a practical use for contraceptive products would be to maintain a wildlife population at a desired level after reduction of the population by other means.
SUMMARY
Currently, two oral contraceptive products (Ovocontrol G for use to manage resident Canada geese, and Ovocontrol P to manage pigeons) are available for commercial use in the USA. In addition, the injectable immunocontraceptive GonaCon has been registered in the USA for use in white-tailed deer. Other chemicals and vaccines are in various stages of development and testing by various agencies and organizations in the USA, Europe, Australia, New Zealand and elsewhere.
There are several factors that will determine when and where contraceptives will be useful for managing overabundant wildlife. The biological feasibility of using contraceptives to manage wildlife populations depends on the age at first reproduction and the adult survival rate. For animals that first breed at one or two years of age, either contraception or lethal control can be more efficient depending on the adult survival rate. However, for animals that first breed at three years of age, lethal control will be more efficient than contraception for reducing populations, regardless of the adult survival rate. This means that reproductive control will be most effective in managing species such as rodents or some bird species with high reproductive rates and low survival rates. For long-lived wildlife species like deer, it may be prudent to reduce the population herd to a desired number by some other management technique before applying fertility control to stabilize herd growth.
In addition to being biologically feasible, infertility agents will need to be economically practical. The cost of development and authorization of the contraceptive, as well as costs of treatment, including labor, equipment and contraceptive must be taken into account. Contraceptives also need to be evaluated for health effects: are they safe for the target animals, for non-target animals, and for humans? The regulatory agencies that register contraceptives for use play a large role in ensuring that wildlife and human health and safety are considered. In addition, because currently available infertility agents are not species-specific, delivery systems need to be developed to limit effects on non-target species. Delivery mechanisms such as injection require direct contact with animals and will not affect non-target species, but use of oral bait delivery systems should be designed to exclude most nontargets. Contraceptives used on huntable species of wildlife pose a potential safety risk to humans who may consume them. All of the currently registered contraceptives have been thoroughly evaluated by the appropriate regulatory agency and have been found to pose minimal risk to target or non-target species, humans or to the environment.
The public is increasingly requesting the use of nonlethal techniques when managing wildlife, including contraceptives, and communities are sometimes willing to fund reproductive control of wildlife populations. Wildlife agencies and biologists have been reluctant to acknowledge the potential applicability of fertility control for managing wildlife populations, in part because fertility control has been publicized as a replacement for sport hunting. In reality, neither the cost nor efficiency of delivery for contraceptive techniques would allow their use on free-ranging game populations outside urban areas. However, wildlife management agencies are increasingly willing to view fertility control as an alternative to other management tools for non-game species and for game species in areas where hunting is restricted. The challenges for wildlife managers will be to integrate contraceptive technologies with more conventional methods of wildlife population management.
